PROM1 and glioblastoma: Prominin-1, or CD133, is a widely explored CSC biomarker associated with normal neural stem cells, and thus is commonly used in glioblastomas, together with other CSC markers such as CD24, CD44, CXCR4, Oct3/4, and Nanog.